Clinical trials
Thyroid Nodule trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
90 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 5 |
| 2015 | 5 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 2 |
| 2019 | 5 |
| 2020 | 12 |
| 2021 | 5 |
| 2022 | 8 |
| 2023 | 5 |
| 2024 | 8 |
| 2025 | 9 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 39 |
| Unknown status | 24 |
| Recruiting | 17 |
| Terminated | 3 |
| Withdrawn | 2 |
| Not yet recruiting | 2 |
| Active, not recruiting | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The University of Hong Kong | 3 |
| Bezmialem Vakif University | 2 |
| Centre Hospitalier Universitaire de Nīmes | 2 |
| Dicle University | 2 |
| Inha University Hospital | 2 |
| Istanbul University | 2 |
| Luo Dingcun | 2 |
| Pulse Biosciences, Inc. | 2 |
| University Health Network, Toronto | 2 |
| University of Florida | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thyroid Nodule | 90 |
| Thyroid Neoplasms | 29 |
| Thyroid Diseases | 11 |
| Goiter | 7 |
| Disease | 5 |
| Goiter, Nodular | 4 |
| Graves Disease | 3 |
| Thyroiditis | 3 |
| Anxiety Disorders | 1 |
| Arthritis, Rheumatoid | 1 |
Trials
Showing 1 to 25 of 90. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.